Tributary Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Tributary Capital Management’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13M	Buy	283,688 +30,704	+12%	+$1.53M	1.19%	44
2026 Q2	$12M	Sell	252,984 -7,478	-3%	-$384K	0.98%	52
2026 Q1	$15.4M	Buy	260,462 +36,925	+17%	+$2.4M	1.5%	26
2025 Q4	$13.8M	Buy	223,537 +33,832	+18%	+$2.07M	1.36%	39
2025 Q3	$11.8M	Buy	189,705 +42,264	+29%	+$2.94M	1.07%	48
2025 Q2	$11.8M	Buy	+147,441	New	+$12.3M	1.04%	51

Other funds holding PBH

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Leeward Investments Boston, Massachusetts $1.98B AUM 28.98% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Nicholas Company Milwaukee, Wisconsin $5.45B AUM 19.89% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $24.3B AUM 19.37% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Tributary Capital Management's PBH Position: Q3 2026 in Review

Tributary Capital Management increased its Prestige Consumer Healthcare (PBH) stake by 12% in Q3 2026, buying an estimated $1.53M and bringing the position to 283,688 shares worth $13M. The position accounts for 1.19% of the portfolio, ranked #44.

Tributary Capital Management first reported a position in PBH in Q2 2025 and has held it in 6 quarters since. The position peaked at $15.4M in Q1 2026. 120 funds tracked by Wall St. Rank hold PBH as of Q3 2026.

Tributary Capital Management held 283,688 shares of Prestige Consumer Healthcare worth $13M as of Q3 2026.
Tributary Capital Management bought 30,704 Prestige Consumer Healthcare shares in Q3 2026, an estimated $1.53M.
Prestige Consumer Healthcare made up 1.19% of Tributary Capital Management's portfolio in Q3 2026, its #44 holding.
Tributary Capital Management first reported a position in Prestige Consumer Healthcare in Q2 2025 and has held it in 6 quarters since.
Tributary Capital Management's Prestige Consumer Healthcare position peaked at $15.4M in Q1 2026.
120 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2026.

Based on Tributary Capital Management's 13F filing for Q3 2026, filed 28 Oct 2026.